How to manage patients on long-acting injectable (LAI, or depot) antipsychotics during the COVID-19 pandemic, NIHR
This guidance includes information about LAI antipsychotic medications which are currently licensed in the UK (that is: Xeplion ® , Trevicta ® , Abilify Maintena ® , Risperdal Consta ® , Zypadhera ® )
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news
More News: Abilify | COVID-19 | Health | National Institute for Health Research (NIHR) | Pandemics | Risperdal Consta